.
Feedback

Sabean Has to Up his Average for Offense to Improve

Giants G.M. missed when signing most hitters in 2011, must unearth leadoff hitter to begin offseason.

Maybe the proverbial World Series hangover carried over into the general manager’s office. Or maybe the law of averages was just catching up with him after a 2010 season in which it seemed he could do no wrong.

Whatever the case, nearly all of the hitters Brian Sabean signed last fall flopped as the Giants produced a historically bad year of offense that left the reigning champs out of the playoffs. And with the team’s internal evaluation meetings now well underway, it shouldn’t escape notice that the member of the organization that most needs to improve his batting average is the general manager himself.

Coming off the championship season, Sabean opted to largely stick with the same hitters who made that dream run possible. The Giants re-upped free agents Aubrey Huff and Pat Burrell, and signed arbitrational-eligible players in Cody Ross, Andres Torres and Mike Fontenot. Free agent shortstop Miguel Tejada was brought in to replace Juan Uribe, who spurned San Francisco to sign with the Dodgers.

But Sabean’s decisions backfired in a big way, as all of those players regressed noticeably from 2010, even rivaling their career-worst seasons in many cases. The disappointing performances of those players coupled with the season-ending injuries of Buster Posey and Freddy Sanchez resulted in the Giants scoring their fewest runs (570) in a non-strike year since 1985, the franchise’s lone 100-loss season.

So what’s the prognosis for a significantly-improved offense in 2012? Murky, at best.

Fortunately for Sabean and the Giants, the underperforming 2011 signees were all inked to one-year deals with the exception of the first baseman Huff (two years, $22 million). Don’t expect any of the others to be back in a starting role, and maybe not at all.

But with Sabean already making it known that his first priority is to secure the team’s standout (and expensive) pitching staff, he will have to be creative (read: frugal) in piecing together an offense.

The Giants have big question marks at shortstop, centerfield and leftfield, and they have a cavernous hole at the leadoff spot in the order.

How the team evaluates a trio of its unproven players – Brandon Crawford, Brandon Belt and Brett Pill – will be a central part of the offseason decision-making.

Even if the Giants decide to hand Crawford the reins at shortstop after he hit .204 in 196 at-bats as a rookie, they will no doubt seek to bring in a capable veteran as an insurance policy. First basemen Belt and Pill have both been asked to play outfield when they suit up for winter ball, and the team will be keen to see if either can make a run at a potential leftfield opening in spring training.

San Francisco is expected to be a player in the Carlos Beltran sweepstakes, but the team is unlikely to craft its entire offseason around re-signing its free-agent right fielder – lest the star sign elsewhere late in the game and leave the Giants without other options. Manager Bruce Bochy has already penciled Nate Schierholtz in as his right fielder, a strong sign the team is already making contingency plans.

But Sabean’s biggest task is to unearth a leadoff hitter – via free agency or trade. The single biggest reason the offense sputtered in 2011 – scoring 127 fewer runs than it did the year before -- was that the Giants leadoff men batted a combined .232 while reaching base at a woeful clip of .292.

Look for Sabean to find his 2012 leadoff hitter first – and then to let the position that player plays (centerfield? shortstop? leftfield?) dictate the subsequent signings.

After swinging and missing repeatedly in signing hitters last offseason, Sabean is stepping up to the plate again. The Giants need him to refine his batting stroke this offseason, lest they let another remarkable year of pitching go by the wayside.

Newsletter & Alerts

Get the best stories each day and important breaking news

Subscribe

Not from Pacifica Patch? Find your Local Patch »

Loading comments ...
Note Article
Just a short thought to get the word out quickly about anything in your neighborhood.
Share something with your neighbors. Write a new post... What's up? Make an announcement, speak your mind, or sell something
Janet Arline Barker May 17, 2013 at 11:18 am
Awesome! Next Tuesday, Thursday or Friday are open. Name a time and place. I used to write 3Read More different columns for San Bruno, Millbrae, and Burlingame Patch. I am ready to write for Pacifica Patch & blog too. Here's my personal blog...I do sporadically. Www.art-Janet.blogspot.com My art studio is at Sanchez Art Center #11
Christa Bigue (Editor) May 17, 2013 at 11:05 am
When can we meet for coffee Janet? Since you're the first one to post in our biz update section youRead More get to have coffee and chat with your local Patch editor! Email me at christa.bigue@patch.com and we'll find a date and place.
Anon. April 14, 2013 at 01:43 am
I can start with the comments on the Theravance drug, fluticasone fluroate - the active moiety inRead More this compound is the same, fluticasone (proprionate) that has been marketed by GSK for the same indication for approximately 25 years. Indeed, that patent is so old, and the drug has such a proven track record for safety and efficacy, that the patent has expired and there are generic versions available. There is also in implicit assumption by the author that the only reason that the FDA will approve medications in a short time span is because they are for 'life-or-limb' or unmet serious medical need. This is just not the case - regulators in many countries, including the FDA in the USA, may give accelerated approval to a product, where the safety and tolerability of a product is equivalent to a similar active agent which has already been approved. I suspect this is the case for fluticasone fluroate - but I am not privy to the details of the regulatory filing. I note that none of the companies mentioned here, nor the FDA, has provided input to this article. The journalism in this article smacks of someone trying to make a name for themselves quickly by scaring uneducated and/or anxious people. The science is just plain flawed.
Pacificat April 12, 2013 at 12:49 pm
Please tell us in what ways it is ill-informed
Anon. April 11, 2013 at 08:22 pm
Ill-informed, sensationalist rubbish.
Deb Wong March 26, 2013 at 06:09 pm
Thanks, Stacie!
Stacie Chan (Editor) March 26, 2013 at 02:51 pm
Absolutely stunning photos, Deb! Thanks for sharing. I really feel like I was there by just perusingRead More your photo gallery.
Donna Fentanes March 26, 2013 at 09:49 am
Thanks, Deb, for the videos. Now we all can take one last ride. :)
Jim Clifford March 25, 2013 at 01:08 pm
Each column gets better. I look for "The Shoe."
Deb Wong March 25, 2013 at 11:19 am
I think many of us can relate! 10 kids, huh? I was the oldest of 9, so sort of understand. MyRead More family grew up in Pacifica, & we rode over the slide every weekend when we went to the HMB airport to tend to my father's airplanes. I drove on it once, during driver's ed in high school, scary! I have an old home movie clip from 1966, going over the slide. Very overexposed, but you can still see parts of the slide in it. More recently, took 2 videos of our drive over the slide, North & south views. Going North: http://www.youtube.com/watch?v=Kb8NKnu9Gvw Going South: http://www.youtube.com/watch?v=-rlN_g2LeE8